Literature DB >> 24322975

Cardiovascular disease in CKD in 2013: Reducing cardiovascular risk--light at the end of the tunnel.

Jessica Kendrick1, Michel Chonchol2.   

Abstract

During 2013, a meta-analysis provided evidence that cystatin C improves estimated glomerular filtration rate in cardiovascular risk categorization in chronic kidney disease (CKD). Another study showed that low diastolic blood pressure (DBP) is harmful in patients with CKD, challenging the paradigm of treating elevated systolic blood pressure regardless of DBP. Overall, mortality rates in CKD have decreased but further improvement is required.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24322975     DOI： 10.1038/nrneph.2013.260

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


  9 in total

1.  'United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States.

Authors:  Allan J Collins; Robert N Foley; Blanche Chavers; David Gilbertson; Charles Herzog; Kirsten Johansen; Bertram Kasiske; Nancy Kutner; Jiannong Liu; Wendy St Peter; Haifeng Guo; Sally Gustafson; Brooke Heubner; Kenneth Lamb; Shuling Li; Suying Li; Yi Peng; Yang Qiu; Tricia Roberts; Melissa Skeans; Jon Snyder; Craig Solid; Bryn Thompson; Changchun Wang; Eric Weinhandl; David Zaun; Cheryl Arko; Shu-Cheng Chen; Frank Daniels; James Ebben; Eric Frazier; Christopher Hanzlik; Roger Johnson; Daniel Sheets; Xinyue Wang; Beth Forrest; Edward Constantini; Susan Everson; Paul Eggers; Lawrence Agodoa
Journal:  Am J Kidney Dis       Date:  2012-01       Impact factor: 8.860

2.  Blood pressure and mortality in U.S. veterans with chronic kidney disease: a cohort study.

Authors:  Csaba P Kovesdy; Anthony J Bleyer; Miklos Z Molnar; Jennie Z Ma; John J Sim; William C Cushman; L Darryl Quarles; Kamyar Kalantar-Zadeh
Journal:  Ann Intern Med       Date:  2013-08-20       Impact factor: 25.391

3.  Cystatin C versus creatinine in determining risk based on kidney function.

Authors:  Michael G Shlipak; Kunihiro Matsushita; Johan Ärnlöv; Lesley A Inker; Ronit Katz; Kevan R Polkinghorne; Dietrich Rothenbacher; Mark J Sarnak; Brad C Astor; Josef Coresh; Andrew S Levey; Ron T Gansevoort
Journal:  N Engl J Med       Date:  2013-09-05       Impact factor: 91.245

4.  The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report.

Authors:  Andrew S Levey; Paul E de Jong; Josef Coresh; Meguid El Nahas; Brad C Astor; Kunihiro Matsushita; Ron T Gansevoort; Bertram L Kasiske; Kai-Uwe Eckardt
Journal:  Kidney Int       Date:  2010-12-08       Impact factor: 10.612

5.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.

Authors:  Alan S Go; Glenn M Chertow; Dongjie Fan; Charles E McCulloch; Chi-yuan Hsu
Journal:  N Engl J Med       Date:  2004-09-23       Impact factor: 91.245

6.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

7.  Cardiovascular effects of sevelamer in stage 3 CKD.

Authors:  Colin D Chue; Jonathan N Townend; William E Moody; Daniel Zehnder; Nadezhda A Wall; Lorraine Harper; Nicola C Edwards; Richard P Steeds; Charles J Ferro
Journal:  J Am Soc Nephrol       Date:  2013-04-18       Impact factor: 10.121

8.  Mortality risk among children initially treated with dialysis for end-stage kidney disease, 1990-2010.

Authors:  Mark M Mitsnefes; Benjamin L Laskin; Mourad Dahhou; Xun Zhang; Bethany J Foster
Journal:  JAMA       Date:  2013-05-08       Impact factor: 56.272

Review 9.  Phosphate: the new cholesterol? The role of the phosphate axis in non-uremic vascular disease.

Authors:  Timothy J Ellam; Timothy J A Chico
Journal:  Atherosclerosis       Date:  2011-09-09       Impact factor: 5.162
  9 in total
  4 in total

1.  Estimated Glomerular Filtration Rate, Activation of Cardiac Biomarkers and Long-Term Cardiovascular Outcomes: A Population-Based Cohort.

Authors:  Shravya Vinnakota; Christopher G Scott; Richard J Rodeheffer; Horng H Chen
Journal:  Mayo Clin Proc       Date:  2019-10-23       Impact factor: 7.616

2.  Sex Differences in Cardiovascular Outcomes in CKD: Findings From the CRIC Study.

Authors:  Stephanie M Toth-Manikowski; Wei Yang; Lawrence Appel; Jing Chen; Rajat Deo; Anne Frydrych; Marie Krousel-Wood; Mahboob Rahman; Sylvia E Rosas; Daohang Sha; Jackson Wright; Martha L Daviglus; Alan S Go; James P Lash; Ana C Ricardo
Journal:  Am J Kidney Dis       Date:  2021-04-20       Impact factor: 11.072

3.  Emergency Department/Urgent Care as Usual Source of Care and Clinical Outcomes in CKD: Findings From the Chronic Renal Insufficiency Cohort Study.

Authors:  Stephanie M Toth-Manikowski; Jesse Y Hsu; Michael J Fischer; Jordana B Cohen; Claudia M Lora; Thida C Tan; Jiang He; Raquel C Greer; Matthew R Weir; Xiaoming Zhang; Sarah J Schrauben; Milda R Saunders; Ana C Ricardo; James P Lash
Journal:  Kidney Med       Date:  2022-02-01

4.  Performance evaluation between two automated biochemical analyzer systems: Roche Cobas 8000 and Mindray BS2000M.

Authors:  Mingxing Chen; Simeng Qin; Sitao Yang; Huaping Chen; Liuyi Lu; Xue Qin
Journal:  J Med Biochem       Date:  2022-07-29       Impact factor: 2.157
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.